Basket

  Untick selected:   0
  1. Efficacy and safety of trastuzumab emtansine plus capecitabine vs trastuzumab emtansine alone in patients with previously treated ERB2 (HER2)-positive metastatic breast cancer: a phase 1 and randomized phase 2 trial  / Cortés, J. ... [et al.] .  Onkológia. - ISSN 1336-8176 . - Roč. 15, č. 4 (2020), s. 304  
    C 3069
    article

    article


  This site uses cookies to make them easier to browse. Learn more about how we use cookies.